BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16969094)

  • 1. Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells.
    Wacheck V; Cejka D; Sieghart W; Losert D; Strommer S; Crevenna R; Monia BP; Selzer E
    Cancer Biol Ther; 2006 Oct; 5(10):1348-54. PubMed ID: 16969094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
    Kondo S; Shinomura Y; Kanayama S; Higashimoto Y; Kiyohara T; Zushi S; Kitamura S; Ueyama H; Matsuzawa Y
    Oncogene; 1998 Nov; 17(20):2585-91. PubMed ID: 9840921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells.
    Akagi H; Higuchi H; Sumimoto H; Igarashi T; Kabashima A; Mizuguchi H; Izumiya M; Sakai G; Adachi M; Funakoshi S; Nakamura S; Hamamoto Y; Kanai T; Takaishi H; Kawakami Y; Hibi T
    Gastric Cancer; 2013 Jan; 16(1):100-10. PubMed ID: 22527182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
    Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
    Sieghart W; Losert D; Strommer S; Cejka D; Schmid K; Rasoul-Rockenschaub S; Bodingbauer M; Crevenna R; Monia BP; Peck-Radosavljevic M; Wacheck V
    J Hepatol; 2006 Jan; 44(1):151-7. PubMed ID: 16289418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.
    Song L; Coppola D; Livingston S; Cress D; Haura EB
    Cancer Biol Ther; 2005 Mar; 4(3):267-76. PubMed ID: 15753661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells.
    Shieh JJ; Liu KT; Huang SW; Chen YJ; Hsieh TY
    J Invest Dermatol; 2009 Oct; 129(10):2497-506. PubMed ID: 19369967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide.
    Thallinger C; Wolschek MF; Maierhofer H; Skvara H; Pehamberger H; Monia BP; Jansen B; Wacheck V; Selzer E
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4185-91. PubMed ID: 15217956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.
    Thallinger C; Wolschek MF; Wacheck V; Maierhofer H; Günsberg P; Polterauer P; Pehamberger H; Monia BP; Selzer E; Wolff K; Jansen B
    J Invest Dermatol; 2003 Jun; 120(6):1081-6. PubMed ID: 12787138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma.
    Ozvaran MK; Cao XX; Miller SD; Monia BA; Hong WK; Smythe WR
    Mol Cancer Ther; 2004 May; 3(5):545-50. PubMed ID: 15141012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Mcl-1 antisense oligonucleotide on Hela cell biology and sensitivity of chemotherapy].
    Li S; Zhong J; Shi Y; Fan S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):640-5. PubMed ID: 21873789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck.
    Skoda C; Erovic BM; Wachek V; Vormittag L; Wrba F; Martinek H; Heiduschka G; Kloimstein P; Selzer E; Thurnher D
    Oncol Rep; 2008 Jun; 19(6):1499-503. PubMed ID: 18497956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.
    Derenne S; Monia B; Dean NM; Taylor JK; Rapp MJ; Harousseau JL; Bataille R; Amiot M
    Blood; 2002 Jul; 100(1):194-9. PubMed ID: 12070027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the her-2/neu (c-erbB-2) gene.
    Funato T; Kozawa K; Fujimaki S; Miura T; Kaku M
    Chemotherapy; 2001; 47(4):297-303. PubMed ID: 11399867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1.
    Lin MT; Juan CY; Chang KJ; Chen WJ; Kuo ML
    Carcinogenesis; 2001 Dec; 22(12):1947-53. PubMed ID: 11751424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
    Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
    Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
    Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
    Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effects of nutlin-3 on TRAIL- and docetaxel-induced apoptosis due to upregulation of TRAIL-R2 and Mcl-1 in human melanoma cells.
    Tseng HY; Jiang CC; Croft A; Tay KH; Thorne RF; Yang F; Liu H; Hersey P; Zhang XD
    Mol Cancer Ther; 2010 Dec; 9(12):3363-74. PubMed ID: 21159614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells.
    Song MQ; Zhu JS; Chen JL; Wang L; Da W; Zhu L; Zhang WP
    World J Gastroenterol; 2007 Mar; 13(12):1788-93. PubMed ID: 17465467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.